Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism α2C-AR antagonists(Alpha-2c adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Depressive Disorder | Preclinical | South Korea | 01 Feb 2026 |





